Subcutaneous Use of a Fast-Acting Insulin Analog: An alternative treatment for pediatric patients with diabetic ketoacidosis

OBJECTIVE:--To look for technical simplification and economic efficiency in the treatment of pediatric diabetic ketoacidosis (DKA) with subcutaneous use of the fast-acting insulin analog (lispro) and compare its use with regular intravenous insulin treatment. RESEARCH DESIGN AND METHODS--In this con...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2005-08, Vol.28 (8), p.1856-1861
Hauptverfasser:	Della Manna, Thais, Steinmetz, Leandra, Campos, Paula R, Farhat, Sylvia C.L, Schvartsman, Cláudio, Kuperman, Hilton, Setian, Nuvarte, Damiani, Durval
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood Glucose - metabolism Child Diabetes Diabetes in children Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - psychology Diabetes. Impaired glucose tolerance Diabetic acidosis Diabetic Ketoacidosis - prevention & control Dosage and administration Drug therapy Drug use Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Injections, Subcutaneous Insulin Insulin - administration & dosage Insulin - adverse effects Insulin - analogs & derivatives Insulin - therapeutic use Insulin Lispro Ketoacidosis Male Medical sciences Medical treatment Patient Compliance Pediatrics Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!